Posted Nov. 20, 2012 at 5:53 a.m.

Premium Lock FDA approves hepatitis-related drug purchased by GSK

Published: 2012-11-20 05:53:00
Updated: 2012-11-20 05:53:00

Print this blog post
GSK GSK Image 1 of 3 · Next Image…

A drug developed by Ligand Pharmaceuticals for treatment of hepatitis C patients with low blood platelet counts and purchased by GSK wins approval from the FDA....

Read More
Read More

WRAL Tech Wire any time: Twitter, Facebook

Copyright 2014 WRAL Tech Wire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL Tech Wire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Frank Vinluan
Life science
Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Scroll